Company Data

Cartesian Therapeutics Inc.

Ticker
RNAC
Current Price
$9.59 -4.1%
Market Cap
$248.9M
Price Target
Refer to Report
Volume
22.5K
52wk Range
$8.46 - $41.87
Advanced Market Data

Overview

Selecta Biosciences Inc is a clinical-stage biopharmaceutical company. The company uses its ImmTOR immune tolerance platform, which is designed to give rise to antigen-specific immunity, mitigating unwanted immune responses. Its product pipeline includes MMA-101, SEL-212 for Chronic Severe Gout, SEL-313 for Ornithine Transcarbamylase Deficiency (OTC), and others.

Inbox Intel from Channelchek.

Informed investors make more money. And it’s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy